News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Immune Oncology
Breast Oncology
Gastrointestinal Oncology
Lung Oncology
Hematology
Radiotherapy
Cancer Types
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025

OncoDaily Medical Journal
OncoDaily Newsletters
OncoDaily Magazine
CancerWorld Magazine
World Health Magazine
Hemostasis Today
Fertility News

OncoDaily GI
OncoDaily Breast
OncoDaily IO
OncoDaily Lung
OncoDaily RT
OncoDaily GU
OncoDaily AI
OncoDaily Biotech
Hematology

About OncoDaily
Services
Partners
P53 Inc
Privacy Policy
Contact Us
Editorial Policy
Disclaimer
Cookie Policy

Sep / 2026

September 2026
M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

« Aug

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target

Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

Cancer Immunotherapy: 2016 vs 2026

Cancer Immunotherapy: 2016 vs 2026

Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04

Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04

Jose Pacheco: Tambotatug Pelitecan Shows Superior Survival in Small Cell Lung Cancer

Jose Pacheco: Tambotatug Pelitecan Shows Superior Survival in Small Cell Lung Cancer

ACT 4 Children Calls for Global Action and Healthcare Equity During Childhood Cancer Awareness Month

ACT 4 Children Calls for Global Action and Healthcare Equity During Childhood Cancer Awareness Month

10 Must-Read Posts In GU Oncology This Week

10 Must-Read Posts In GU Oncology This Week

Diego A. Díaz-García: PAPILLON Delivers New Overall Survival Data in EGFR Ex20ins NSCLC

Diego A. Díaz-García: PAPILLON Delivers New Overall Survival Data in EGFR Ex20ins NSCLC

manuscript

Apr 24, 2024 9:37 am

Blog Posts

Douglas Flora: The New Issue of AI in Precision Oncology!

Douglas Flora: The New Issue of AI in Precision Oncology!

Apr 23, 2024 8:12 pm

Blog Posts

Antonio Passaro: An honor to have been a part of this significant manuscript, just out in Annals of Oncology driving forward the clinical development of ADCs

Antonio Passaro: An honor to have been a part of this significant manuscript, just out in Annals of Oncology driving forward the clinical development of ADCs

Jan 2, 2024 5:36 am

Blog Posts

Anna Clemens: 5 most common reasons a paper gets desk-rejected

Anna Clemens: 5 most common reasons a paper gets desk-rejected

Nov 7, 2023 6:37 pm

Blog Posts

Mark Lewis: Authorship sequence is broken

Mark Lewis: Authorship sequence is broken

Oct 12, 2023 1:07 am

Opinion

Katrina Pedersen: P.S. Calling a trial “First-In-Man” will earn autorejection

Katrina Pedersen: P.S. Calling a trial “First-In-Man” will earn autorejection

Aug 15, 2023 7:20 pm

Blog Posts

Ajay Major: Our multicenter study of checkpoint inhibitor outcomes in the post-CAR-T setting is now published online in full at Blood Advances

Ajay Major: Our multicenter study of checkpoint inhibitor outcomes in the post-CAR-T setting is now published online in full at Blood Advances

Aug 1, 2023 6:35 pm

Blog Posts

Authors of accepted abstracts will be given opportunity and guidance by mentors and peers to develop their research into a paper – Herbert Loong

Authors of accepted abstracts will be given opportunity and guidance by mentors and peers to develop their research into a paper – Herbert Loong

Jul 26, 2023 8:48 pm

Insight

Obesity-associated changes in molecular biology of primary breast cancer

Obesity-associated changes in molecular biology of primary breast cancer

Headlines

Pavlos Msaouel: Rethinking Clinical Trial Design for Rare RCC Subtypes

Beyond ctDNA: Unlocking Tissue Insights in MRD

10 Must-Read Posts In GI Oncology This Week

Gilberto Lopes: Key Insights From WCLC26

Dario Trapani: Discussing Innovation, Access and Sustainability in European Oncology

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer Breast Cancer cancer care ASCO Lung cancer fight against cancer Cancer research Global fight against cancer Headlines immunotherapy ESMO NSCLC cancer treatment MD Anderson Cancer Center clinical trials colorectal cancer cancer awareness prostate cancer FDA Childhood Cancer Research UICC AACR ASCO24 chemotherapy Pancreatic Cancer radiation oncology Dana-Farber Cancer Institute American Cancer Society Precision Oncology AI Robert Orlowski American Society of Clinical Oncology SIOP NCI European Cancer Organisation National Cancer Institute Myeloma Paper of the Day WHO radiotherapy cervical cancer Paolo Tarantino Myeloma IASLC Vivek Subbiah bladder cancer multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}